RAS proteins function as on/off switches in pathways controlling cell growth and proliferation. Mutated RASs keep the pathways permanently activated, leading to conditions such as cancer and Noonan syndrome. Scientists have revealed how mutations in a particular protein disrupt RAS binding. Their findings support development of a molecular glue that could promote reduction of cancer-causing proteins.